SCHEMBL10970619

SCHEMBL10970619

Cc1nc2c(c(-c3cccc([N+](=O)[O-])c3)c1OC(=O)OC(C)C)C(=O)OC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.38
▸ PKM P14618 1/20 0.38
▸ AKR1C3 P42330 3/20 0.38
▸ AKR1C2 P52895 3/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ACHE P22303 2/20 0.37
▸ CACNA1C Q13936 2/20 0.37
▸ CACNB4 O00305 1/20 0.37
▸ CACNA1A O00555 1/20 0.37
▸ CACNA1G O43497 1/20 0.37
▸ CACNG3 O60359 1/20 0.37
▸ CACNA1F O60840 1/20 0.37
▸ CACNA1H O95180 1/20 0.37
▸ BCHE P06276 1/20 0.37
▸ CACNB3 P54284 1/20 0.37
▸ CACNA2D1 P54289 1/20 0.37
▸ CACNG7 P62955 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10921450 0.92 ALDH1A1 (0.44) ALDH1A1PKMAKR1C3AKR1C2MEN1
SCHEMBL10920420 0.86 ALDH1A1 (0.46) ALDH1A1PKMAKR1C3AKR1C2MEN1
SCHEMBL10914189 0.86 ACHE (0.39) ALDH1A1PKMMEN1KMT2AACHE
SCHEMBL11009475 0.85 CACNA1C (0.45) ALDH1A1PKMAKR1C3AKR1C2MEN1
SCHEMBL11197176 0.85 CACNA1C (0.39) ALDH1A1PKMMEN1KMT2ATDP1
SCHEMBL10924017 0.83 AKR1C3 (0.45) ALDH1A1PKMAKR1C3AKR1C2MEN1
SCHEMBL8803416 0.81 SLC6A3 (0.38) AKR1C3AKR1C2MEN1KMT2A
SCHEMBL10924663 0.81 MAPT (0.46) ALDH1A1PKMMEN1KMT2ATDP1
SCHEMBL10911153 0.79 ALDH1A1 (0.43) ALDH1A1PKMAKR1C3AKR1C2MEN1
SCHEMBL10915211 0.79 ALDH1A1 (0.43) ALDH1A1PKMAKR1C3AKR1C2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0088938-B1 USE OF PYRIDINE COMPOUNDS FOR THE MANUFACTURE OF MEDICAMENTS WITH AN ANTIHYPOXEMIA AND ISCHEMIA-PROTECTIVE ACTIVITY BAYER AG (DE) 1986-04-30 — — EP disclosed
EP-0088938-A1 Use of pyridine compounds for the manufacture of medicaments with an antihypoxemia and ischemia-protective activity BAYER AG (DE) 1983-09-21 — — EP disclosed
Send feedback